These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 27122661)

  • 1. Adult mouse model of early hepatocellular carcinoma promoted by alcoholic liver disease.
    Ambade A; Satishchandran A; Gyongyosi B; Lowe P; Szabo G
    World J Gastroenterol; 2016 Apr; 22(16):4091-108. PubMed ID: 27122661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NADPH Oxidase 1 in Liver Macrophages Promotes Inflammation and Tumor Development in Mice.
    Liang S; Ma HY; Zhong Z; Dhar D; Liu X; Xu J; Koyama Y; Nishio T; Karin D; Karin G; Mccubbin R; Zhang C; Hu R; Yang G; Chen L; Ganguly S; Lan T; Karin M; Kisseleva T; Brenner DA
    Gastroenterology; 2019 Mar; 156(4):1156-1172.e6. PubMed ID: 30445007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alcoholic hepatitis accelerates early hepatobiliary cancer by increasing stemness and miR-122-mediated HIF-1α activation.
    Ambade A; Satishchandran A; Szabo G
    Sci Rep; 2016 Feb; 6():21340. PubMed ID: 26888602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocellular carcinoma is accelerated by NASH involving M2 macrophage polarization mediated by hif-1
    Ambade A; Satishchandran A; Saha B; Gyongyosi B; Lowe P; Kodys K; Catalano D; Szabo G
    Oncoimmunology; 2016; 5(10):e1221557. PubMed ID: 27853646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-saturate-fat diet delays initiation of diethylnitrosamine-induced hepatocellular carcinoma.
    Duan XY; Pan Q; Yan SY; Ding WJ; Fan JG; Qiao L
    BMC Gastroenterol; 2014 Nov; 14():195. PubMed ID: 25410681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abberent expression of NOR1 protein in tumor associated macrophages contributes to the development of DEN-induced hepatocellular carcinoma.
    Chen S; Zheng P; Wang W; Yi M; Chen P; Cai J; Li J; Peng Q; Ban Y; Zhou Y; Zeng Z; Li X; Xiong W; Li G; Xiang B
    J Cell Physiol; 2018 Jun; 233(6):5002-5013. PubMed ID: 29227538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological Inhibition of CCR2/5 Signaling Prevents and Reverses Alcohol-Induced Liver Damage, Steatosis, and Inflammation in Mice.
    Ambade A; Lowe P; Kodys K; Catalano D; Gyongyosi B; Cho Y; Iracheta-Vellve A; Adejumo A; Saha B; Calenda C; Mehta J; Lefebvre E; Vig P; Szabo G
    Hepatology; 2019 Mar; 69(3):1105-1121. PubMed ID: 30179264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bile acids promote diethylnitrosamine-induced hepatocellular carcinoma via increased inflammatory signaling.
    Sun L; Beggs K; Borude P; Edwards G; Bhushan B; Walesky C; Roy N; Manley MW; Gunewardena S; O'Neil M; Li H; Apte U
    Am J Physiol Gastrointest Liver Physiol; 2016 Jul; 311(1):G91-G104. PubMed ID: 27151938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a novel mouse model of hepatocellular carcinoma with nonalcoholic steatohepatitis using a high-fat, choline-deficient diet and intraperitoneal injection of diethylnitrosamine.
    Kishida N; Matsuda S; Itano O; Shinoda M; Kitago M; Yagi H; Abe Y; Hibi T; Masugi Y; Aiura K; Sakamoto M; Kitagawa Y
    BMC Gastroenterol; 2016 Jun; 16(1):61. PubMed ID: 27296438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic Alcohol Consumption Promotes Diethylnitrosamine-Induced Hepatocarcinogenesis via Immune Disturbances.
    Yan G; Wang X; Sun C; Zheng X; Wei H; Tian Z; Sun R
    Sci Rep; 2017 May; 7(1):2567. PubMed ID: 28566719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA 122, Regulated by GRLH2, Protects Livers of Mice and Patients From Ethanol-Induced Liver Disease.
    Satishchandran A; Ambade A; Rao S; Hsueh YC; Iracheta-Vellve A; Tornai D; Lowe P; Gyongyosi B; Li J; Catalano D; Zhong L; Kodys K; Xie J; Bala S; Gao G; Szabo G
    Gastroenterology; 2018 Jan; 154(1):238-252.e7. PubMed ID: 28987423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple liver insults synergize to accelerate experimental hepatocellular carcinoma.
    Henderson JM; Polak N; Chen J; Roediger B; Weninger W; Kench JG; McCaughan GW; Zhang HE; Gorrell MD
    Sci Rep; 2018 Jul; 8(1):10283. PubMed ID: 29980757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adaptive immunity suppresses formation and progression of diethylnitrosamine-induced liver cancer.
    Schneider C; Teufel A; Yevsa T; Staib F; Hohmeyer A; Walenda G; Zimmermann HW; Vucur M; Huss S; Gassler N; Wasmuth HE; Lira SA; Zender L; Luedde T; Trautwein C; Tacke F
    Gut; 2012 Dec; 61(12):1733-43. PubMed ID: 22267597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-17 signaling in steatotic hepatocytes and macrophages promotes hepatocellular carcinoma in alcohol-related liver disease.
    Ma HY; Yamamoto G; Xu J; Liu X; Karin D; Kim JY; Alexandrov LB; Koyama Y; Nishio T; Benner C; Heinz S; Rosenthal SB; Liang S; Sun M; Karin G; Zhao P; Brodt P; Mckillop IH; Quehenberger O; Dennis E; Saltiel A; Tsukamoto H; Gao B; Karin M; Brenner DA; Kisseleva T
    J Hepatol; 2020 May; 72(5):946-959. PubMed ID: 31899206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of Hepatic Transcription Factor EB Attenuates Alcohol-Associated Liver Carcinogenesis.
    Chao X; Wang S; Hlobik M; Ballabio A; Ni HM; Ding WX
    Am J Pathol; 2022 Jan; 192(1):87-103. PubMed ID: 34717896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AFP, PIVKAII, GP3, SCCA-1 and follisatin as surveillance biomarkers for hepatocellular cancer in non-alcoholic and alcoholic fatty liver disease.
    Beale G; Chattopadhyay D; Gray J; Stewart S; Hudson M; Day C; Trerotoli P; Giannelli G; Manas D; Reeves H
    BMC Cancer; 2008 Jul; 8():200. PubMed ID: 18638391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of murine alcoholic steatohepatitis by pepducin-based functional blockade of interleukin-8 receptors.
    Wieser V; Adolph TE; Enrich B; Kuliopulos A; Kaser A; Tilg H; Kaneider NC
    Gut; 2017 May; 66(5):930-938. PubMed ID: 26858343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of cannabinoid receptors in alcoholic hepatic injury: steatosis and fibrogenesis are increased in CB2 receptor-deficient mice and decreased in CB1 receptor knockouts.
    Trebicka J; Racz I; Siegmund SV; Cara E; Granzow M; Schierwagen R; Klein S; Wojtalla A; Hennenberg M; Huss S; Fischer HP; Heller J; Zimmer A; Sauerbruch T
    Liver Int; 2011 Jul; 31(6):860-70. PubMed ID: 21645218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The presence of p47phox in liver parenchymal cells is a key mediator in the pathogenesis of alcoholic liver steatosis.
    Levin I; Petrasek J; Szabo G
    Alcohol Clin Exp Res; 2012 Aug; 36(8):1397-406. PubMed ID: 22376231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic inflammation-fibrosis-cancer axis in the rat hepatocellular carcinoma induced by diethylnitrosamine.
    Ding YF; Wu ZH; Wei YJ; Shu L; Peng YR
    J Cancer Res Clin Oncol; 2017 May; 143(5):821-834. PubMed ID: 28238064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.